These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10822370)

  • 1. Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component.
    Kondo Y; Koga S; Komata T; Kondo S
    Oncogene; 2000 Apr; 19(18):2205-11. PubMed ID: 10822370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisense telomerase RNA.
    Koga S; Kondo Y; Komata T; Kondo S
    Gene Ther; 2001 Apr; 8(8):654-8. PubMed ID: 11320413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.
    Mukai S; Kondo Y; Koga S; Komata T; Barna BP; Kondo S
    Cancer Res; 2000 Aug; 60(16):4461-7. PubMed ID: 10969793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
    Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
    Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.
    Yatabe N; Kyo S; Kondo S; Kanaya T; Wang Z; Maida Y; Takakura M; Nakamura M; Tanaka M; Inoue M
    Cancer Gene Ther; 2002 Jul; 9(7):624-30. PubMed ID: 12082463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA.
    Kondo S; Kondo Y; Li G; Silverman RH; Cowell JK
    Oncogene; 1998 Jun; 16(25):3323-30. PubMed ID: 9681832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of 2-5A-linked antisense against telomerase RNA and conventional therapies on human malignant glioma cells in vitro and in vivo.
    Iwado E; Daido S; Kondo Y; Kondo S
    Int J Oncol; 2007 Nov; 31(5):1087-95. PubMed ID: 17912434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate.
    Kondo Y; Kondo S
    Methods Mol Biol; 2007; 405():97-112. PubMed ID: 18369820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid blockade of telomerase activity and tumor cell growth by the DPL lipofection of ribbon antisense to hTR.
    Bajpai AK; Park JH; Moon IJ; Kang H; Lee YH; Doh KO; Suh SI; Chang BC; Park JG
    Oncogene; 2005 Sep; 24(43):6492-501. PubMed ID: 16170384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitro.
    Schindler A; Fiedler U; Meye A; Schmidt U; Füssel S; Pilarsky C; Herrmann J; Wirth MP
    Int J Oncol; 2001 Jul; 19(1):25-30. PubMed ID: 11408918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human telomerase RNA degradation by 2'-5'-linked oligoadenylate antisense chimeras in a cell-free system, cultured tumor cells, and murine xenograft models.
    Paranjape JM; Xu D; Kushner DM; Okicki J; Lindner DJ; Cramer H; Silverman RH; Leaman DW
    Oligonucleotides; 2006; 16(3):225-38. PubMed ID: 16978086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy of 2-5A antisense against telomerase RNA and cisplatin for malignant gliomas.
    Kondo Y; Komata T; Kondo S
    Int J Oncol; 2001 Jun; 18(6):1287-92. PubMed ID: 11351264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of antisense human telomerase RNA toward cancer therapy].
    Naka K; Yokozaki H; Tahara H; Tahara E
    Nihon Rinsho; 1998 May; 56(5):1131-5. PubMed ID: 9613109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of telomerase RNA (hTR) in cervical cancer by adenovirus-delivered siRNA.
    Li Y; Li H; Yao G; Li W; Wang F; Jiang Z; Li M
    Cancer Gene Ther; 2007 Aug; 14(8):748-55. PubMed ID: 17479103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells.
    Kushner DM; Paranjape JM; Bandyopadhyay B; Cramer H; Leaman DW; Kennedy AW; Silverman RH; Cowell JK
    Gynecol Oncol; 2000 Feb; 76(2):183-92. PubMed ID: 10637068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
    Lei LX; Chen ZD
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression-patterns of the RNA component (hTR)and the catalytic subunit (hTERT) of human telomerase in nonneoplastic prostate tissue, prostatic intraepithelial neoplasia, and prostate cancer.
    Bettendorf O; Heine B; Kneif S; Eltze E; Semjonow A; Herbst H; Stein H; Böcker W; Poremba C
    Prostate; 2003 May; 55(2):99-104. PubMed ID: 12661034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
    Nair SK; Heiser A; Boczkowski D; Majumdar A; Naoe M; Lebkowski JS; Vieweg J; Gilboa E
    Nat Med; 2000 Sep; 6(9):1011-7. PubMed ID: 10973321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
    Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S
    Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense telomerase induced cell growth inhibition, cell cycle arrest and telomerase activity down-regulation in gastric and colon cancer cells.
    Wong SC; Yu H; Moochhala SM; So JB
    Anticancer Res; 2003; 23(1A):465-9. PubMed ID: 12680250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.